Global health insurer The Cigna Group delivered solid revenue and earnings growth in 2025, broadly in line with peers across the US managed care sector, with its performance again underscoring the ...

Cigna remains a 'Hold' due to valuation concerns and systemic US healthcare risks despite recent sector underperformance. CI's 2026 AEPS growth forecast has dropped to 2%, with regulatory, legal, and ...

Cigna (CI) reported better-than-expected Q4 2025 financials on Thursday, even as the managed care firm set its full-year earnings guidance below consensus despite an improving outlook for its medical ...

Cigna thinks negative attention on its pharmacy benefit manager Express Scripts is a challenge of the past, after reaching a settlement with the Federal Trade Commission in the agency’s lawsuit ...

Express Scripts to change practices tied to high costs FTC to enforce 10-year settlement Deal requires company to work with local pharmacies Sign up here. "Our ...

Recent commentary on Cigna Group (CI) has become more cautious, with expectations for the upcoming quarter including a 22.2% decline in premiums, fewer medical customers, and pressure from lower net ...